Table 2 |
|||||||
|
Prevalence and Incidence of Celiac Disease (CD) and Seropositivity for IgA Class Tissue Transglutaminase (tTGA) and Endomysial (EmA) Antibodies in Patients Aged Over 55 Years. |
|||||||
|
Year, total population |
Procedure |
Number clinically detected |
tTGA positive in screening |
EmA positive in screening |
Biopsy-proven cases in screening |
Overall frequency of biopsy proven CD |
Patients with CD and tTGA seropositive individuals |
|
|
|||||||
|
2002, 2815 |
Serum sampling |
||||||
|
2004, 2815 |
Recording of detected CD. First serologic analysis |
25 |
48 |
43 |
35 |
60 |
69a |
|
2005, 2216 |
Recording of detected CD. Second serologic screening |
1 |
6 |
4 |
5b |
6 |
7 |
|
Overall prevalence, N = 2815 |
0.92% (26/2815) |
1.92% (54/2815) |
1.70% (47/2815) |
1.42% (40/2815) |
2.34% (66/2815) |
2.70% (76/2815) |
|
|
95% confidence intervals |
0.57–1.27% |
1.41–2.43% |
1.22–2.18% |
0.98–1.86% |
1.78–2.90% |
2.10–3.30% |
|
|
|
|||||||
|
a Four seropositive were found to have celiac disease between 2002–2004 bThe incidence of celiac disease 2002–2005 was 0.23% (5/2216) |
|||||||
|
Vilppula et al. BMC Gastroenterology 2009 9:49 doi:10.1186/1471-230X-9-49 |
|||||||